VI
LGND icon

Vestcor Inc’s Ligand Pharmaceuticals LGND Stock Holding History

Vestcor Inc’s Portfolio LGND Stock Details LGND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-1,293
Closed -$95K – 1225
2024
Q1 		$95K Hold
1,293
– – ﹤0.01% 1107
2023
Q4 		$92K Hold
1,293
– – ﹤0.01% 1094
2023
Q3 		$77K Buy
+1,293
New +$85.1K ﹤0.01% 1150

Other funds holding LGND

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SIMG
Stephens Investment Management Group Houston, Texas $7.3B AUM 41.96% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
CC
Chicago Capital Chicago, Illinois $3.71B AUM 19.51% 1-Year Est. Return
SDJVC
St. Denis J. Villere & Co New Orleans, Louisiana $907M AUM 10.61% 1-Year Est. Return

Vestcor Inc's LGND Position: Q2 2024 in Review

Vestcor Inc sold out of Ligand Pharmaceuticals (LGND) in Q2 2024, closing a stake of 1,293 shares — an estimated $95K sold.

Vestcor Inc first reported a position in LGND in Q3 2023 and held it in 3 quarters. The position peaked at $95K in Q1 2024. 234 funds tracked by Wall St. Rank hold LGND as of Q2 2024.

  • Vestcor Inc reported no remaining Ligand Pharmaceuticals position as of Q2 2024 after selling out during the quarter.
  • Vestcor Inc sold 1,293 Ligand Pharmaceuticals shares in Q2 2024, an estimated $95K.
  • Vestcor Inc first reported a position in Ligand Pharmaceuticals in Q3 2023 and held it in 3 quarters.
  • Vestcor Inc's Ligand Pharmaceuticals position peaked at $95K in Q1 2024.
  • 234 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q2 2024.

Based on Vestcor Inc's 13F filing for Q2 2024, filed 13 Aug 2024.